# Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche

> **NCT05520749** · — · COMPLETED · sponsor: **Fondazione Italiana Sindromi Mielodisplastiche-ETS** · enrollment: 215 (actual)

## Conditions studied

- Myeloid Dysplasia

## Interventions

- **DRUG:** Luspatercept

## Key facts

- **NCT ID:** NCT05520749
- **Lead sponsor:** Fondazione Italiana Sindromi Mielodisplastiche-ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2025-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05520749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05520749, "Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05520749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*